Fatty liver disease

The Fatty Liver Foundation (FLF) is seeking applicants for a first-of-its-kind program that trains patient advocates to become “equal partners” in shaping research, care,…

Global Fatty Liver Day — being held today, on the second Thursday of June — is shining a spotlight on steatotic liver disease…

Summers in Utah, where I grew up, meant hot days spent boating and swimming in lakes. For my friends and me, they also meant drinking…

I start my day every morning by swallowing a handful of pills with water I keep on my nightstand. It has been this way for…

Treatment with Wegovy (semaglutide) showed a consistent safety and efficacy profile across a range of patient subgroups with metabolic dysfunction-associated steatohepatitis (MASH), a serious…

Today, I sat down to go over my upcoming summer doctor appointments because ’tis the season for my annual upper and lower gastrointestinal scopes and…

Long before I ever set foot inside my gastroenterologist’s office to discuss my liver health and metabolic dysfunction-associated steatohepatitis (MASH), I was diagnosed with…

Belapectin, Galectin Therapeutics’ investigational therapy, significantly reduced the development of new enlarged blood vessels in the esophagus among people with metabolic dysfunction-associated steatohepatitis (MASH),…

Your liver may store excess fat when you’re living with metabolic dysfunction-associated steatohepatitis (MASH), but does it also store secrets you’re keeping from your…

Madrigal Pharmaceuticals has secured worldwide rights to develop ARO-PNPLA3, an experimental treatment created by Arrowhead Pharmaceuticals for people with metabolic dysfunction-associated steatohepatitis (MASH),…